Matthew Meyerson
Overview
Explore the profile of Matthew Meyerson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
368
Citations
98464
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sos M, Koker M, Weir B, Heynck S, Rabinovsky R, Zander T, et al.
Cancer Res
. 2025 Mar;
85(5):1003.
PMID: 40025966
No abstract available.
2.
Mostovoy Y, Boone P, Huang Y, Garimella K, Tan K, Russell B, et al.
Am J Hum Genet
. 2024 Nov;
111(12):2693-2706.
PMID: 39520989
Delineation of structural variants (SVs) at sequence resolution in highly repetitive genomic regions has long been intractable. The sequence properties, origins, and functional effects of classes of genomic rearrangements such...
3.
Ter Laak A, Hillig R, Ferrara S, Korr D, Barak N, Lienau P, et al.
J Med Chem
. 2024 Oct;
67(21):19282-19303.
PMID: 39450890
KAT6A and KAT6B genes are two closely related lysine acetyltransferases that transfer an acetyl group from acetyl coenzyme A (AcCoA) to lysine residues of target histone substrates, hence playing a...
4.
Lewis T, Ellermann M, Kopitz C, Lange M, de Waal L, Wu X, et al.
ACS Med Chem Lett
. 2024 Oct;
15(10):1662-1667.
PMID: 39411532
A subset of phosphodiesterase 3 (PDE3) inhibitors kills cancer cells that express both PDE3A and SLFN12 by inducing a protein-protein interaction between the two, triggering SLFN12 tRNase activity. Following discovery...
5.
Greulich H, Chen T, Feng W, Janne P, Alvarez J, Zappaterra M, et al.
PLoS Med
. 2024 Sep;
21(9):e1004470.
PMID: 39284164
[This corrects the article DOI: 10.1371/journal.pmed.0020313.].
6.
Aquilanti E, Goldoni S, Baker A, Kotynkova K, Andersen S, Bozinov V, et al.
Neurooncol Adv
. 2024 Aug;
6(1):vdae115.
PMID: 39166256
Background: Velcrins are molecular glues that kill cells by inducing the formation of a protein complex between the RNase SLFN12 and the phosphodiesterase PDE3A. Formation of the complex activates SLFN12,...
7.
Yermalovich A, Mohsenin Z, Cowdin M, Giotti B, Gupta A, Feng A, et al.
Dev Biol
. 2024 Aug;
516:47-58.
PMID: 39094818
CMTR2 is an mRNA cap methyltransferase with poorly understood physiological functions. It catalyzes 2'-O-ribose methylation of the second transcribed nucleotide of mRNAs, potentially serving to mark RNAs as "self" to...
8.
Tan K, Slevin M, Leibowitz M, Garrity-Janger M, Shan J, Li H, et al.
Cell Genom
. 2024 Jun;
4(7):100588.
PMID: 38917803
Alterations in the structure and location of telomeres are pivotal in cancer genome evolution. Here, we applied both long-read and short-read genome sequencing to assess telomere repeat-containing structures in cancers...
9.
Gupta M, Bradley J, Massaad E, Burns E, Georgantas N, Maron G, et al.
Blood
. 2024 May;
144(10):1093-1100.
PMID: 38776489
Delays and risks associated with neurosurgical biopsies preclude timely diagnosis and treatment of central nervous system (CNS) lymphoma and other CNS neoplasms. We prospectively integrated targeted rapid genotyping of cerebrospinal...
10.
Kim J, Schulte A, Sarver A, Lee D, Angelos M, Frantz A, et al.
Cancer Res Commun
. 2024 May;
4(6):1467-1480.
PMID: 38757809
Significance: We demonstrate that hemangiosarcomas regulate molecular programs supporting hematopoietic expansion and differentiation, providing insights into their potential roles in creating a permissive stromal-immune environment for tumor progression.